Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome. [electronic resource]
Producer: 20110218Description: 1461-7 p. digitalISSN:- 1029-2403
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Transformation, Neoplastic -- drug effects
- Cytarabine -- administration & dosage
- Disease Progression
- Dose-Response Relationship, Drug
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Harringtonines -- administration & dosage
- Homoharringtonine
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Neoadjuvant Therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.